Mundipharma Pharmaceuticals Limited have announced the appointment of Matthew Homent to the position of Ireland Country Manager, a position he has held on an interim basis since April 2019.
Matthew joins Mundipharma Pharmaceuticals Limited from Napp Pharmaceuticals Limited in the UK, where he was Director of Commercial Operations. During his time at Napp, Matthew was integral in setting up a market-leading portfolio of branded generic medicines providing much-needed innovative, high-quality and cost-effective medicines to the NHS.
Matthew has been with the Mundipharma network for over 20 years, moving to Napp in 2003, where he progressed through various procurement and commercial roles before becoming Director of Commercial Operations in 2015.
Commenting on his appointment, Matthew said: “I am delighted, and it is a great privilege, to have the opportunity to lead Mundipharma in Ireland at a particularly exciting time for the company. As a business, we are committed to move medicine forward in Ireland by bringing innovative and cost-effective medicines to our customers, the healthcare professionals, who are helping patients every day to manage their long-term conditions and lead better lives. I am extremely excited for the future of Mundipharma and look forward to working closely with an incredibly talented and ambitious team, who are equally committed to move medicine forward in Ireland.”